Anixa Biosciences Inc.

NASDAQ: ANIX · Real-Time Price · USD
2.97
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
2.97
0.00%
After-hours: Aug 15, 2025, 07:56 PM EDT

Anixa Biosciences Income Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 156K n/a 210K n/a 2.47B n/a n/a n/a 3.61M n/a n/a 512.5K
Cost of Revenue
n/a n/a n/a n/a 12K 13K 12K 11K 161K 11K 11K 10K 11K 10K 385K 15.16K 14.64K 385K
Gross Profit
n/a n/a n/a -3K -12K -13K 144K -11K 49K -11K 2.47B -10K -11K -10K 3.23M -15.16K -14.64K 127.5K
Operating Income
-3M -3.39M -3.16M -3.59M -3.47M -3.61M -3.05M -2.84M -2.56M -2.56M -3.61M -2.8M -3.59M -3.88M -4.08M -4.39M -2.44M -2.23M
Interest Income
190K 173K 250K 277K 287K 319K 330K 296K 253K 202K 80K 22K 1K 1K 549.00 626.00 393.00 1K
Pretax Income
-2.81M -3.21M -2.91M -3.31M -3.18M -3.29M -2.72M -2.55M -2.31M -2.35M -3.53M -2.77M -3.59M -3.88M -4.07M -4.39M -2.44M -2.23M
Net Income
-2.79M -3.18M -2.88M -3.28M -3.14M -3.25M -2.69M -2.51M -2.04M -2.12M -3.4M -2.7M -3.54M -3.83M -4.01M -4.33M -2.4M -2.21M
Selling & General & Admin
1.68M 1.83M 1.69M 1.67M 1.81M 2.25M 1.44M 1.76M 1.61M 1.49M 1.92M 1.35M 1.85M 2.04M 1.9M 2.22M 1.42M 1.53M
Research & Development
1.32M 1.55M 1.48M 1.93M 1.65M 1.35M 1.61M 1.09M 998K 1.07M 1.69M 1.45M 1.74M 1.84M 2.17M 2.17M 1.02M 827.65K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
3M 3.39M 3.16M 3.59M 3.46M 3.6M 3.05M 2.84M 2.61M 2.56M 3.61M 2.8M 3.59M 3.88M 4.08M 4.39M 2.44M 2.36M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 626.00 393.00 n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -12K -13K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3M 3.39M 3.16M 3.59M 3.47M 3.61M 3.05M 2.84M 2.77M 2.56M 3.61M 2.8M 3.59M 3.88M 4.08M 4.39M 2.44M 2.75M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a -272K -234K -133K -73K n/a n/a n/a -54.87K -38.82K -25.59K
Shares Outstanding (Basic)
32.2M 32.2M 31.9M 32.05M 31.91M 31.45M 31.08M 30.97M 30.93M 30.92M 30.76M 30.45M 30.15M 30.13M 30.05M 30.45M 28.67M 25.16M
Shares Outstanding (Diluted)
32.2M 32.2M 31.9M 32.05M 31.91M 31.45M 31.08M 30.97M 30.93M 30.92M 30.76M 30.45M 30.15M 30.13M 30.13M 30.45M 28.67M 25.16M
EPS (Basic)
-0.09 -0.1 0.30 -0.1 -0.1 -0.1 -0.09 -0.08 -0.07 -0.07 -0.11 -0.09 -0.12 -0.13 -0.13 -0.14 -0.08 -0.09
EPS (Diluted)
-0.09 -0.1 0.30 -0.1 -0.1 -0.1 -0.09 -0.08 -0.07 -0.07 -0.11 -0.09 -0.12 -0.13 -0.13 -0.14 -0.08 -0.09
EBITDA
-2.99M -3.39M -3.15M -3.59M -3.47M -3.61M -2.71M -2.84M -2.56M -2.56M -3.52M -2.77M -3.58M -3.87M -4.06M -4.37M -2.42M -2.22M
EBIT
-3M -3.39M -3.16M -3.59M -3.47M -3.61M -3.05M -2.84M -2.56M -2.56M -3.61M -2.8M -3.59M -3.88M -4.08M -4.39M -2.44M -2.23M
Depreciation & Amortization
9K n/a 9K 3K 12K 13K 12K 11K 12K 11K 11K 10K 11K 10K 15.94K 15.16K 14.64K 14K